Both FDA-approved and -unapproved FMT products should play a role in preventing C. diff infections, according to Dr. Jessica Allegretti.
A new appreciation for the impact of metabolic risk factors in ALD may open avenues for new treatments.
AI may soon be able to provide real-time feedback on quality metrics during endoscopic procedures, according to Dr. Nayantara Coelho-Prabhu.
The “radical” idea of laparoscopy went against everything known about mainstream surgery in the 1980s. Drs. Carlos Pellegrini and Nathaniel Soper discuss how laparoscopy revolutionized surgery.
The randomized trial suggests dietary interventions can play a protective role against polyps.
EMVI and positive pelvic sidewall lymph nodes were associated with higher rates of tumor regrowth in patients with rectal cancer.
The proposal focuses on establishing point-of-care testing, increasing medication access among underserved populations, and engaging community organizations to drive awareness and increase screening.
Gastroenterologists should pursue emergent endoscopic removal of foreign objects in those with symptoms of obstruction, says Dr. Sumeet Tewani.
A retrospective cohort study shows that GLP-1 agonists reduced the risk of cirrhosis and HCC in patients with MASLD and Type 2 diabetes.
Dr. Yin Cao’s research links factors such as obesity, metabolic syndrome, prolonged sitting, poor diet and sugar-sweetened beverages with early-onset colorectal cancer.
